Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Dis Esophagus ; 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38661378

ABSTRACT

Dysphagia after esophagectomy is a serious complication; however, no method has been established to accurately assess swallowing function. We evaluated the association of swallowing function tests with patients' post-esophagectomy complications and nutritional statuses. We retrospectively reviewed the data of 95 patients with esophageal cancer who underwent esophagectomy between 2016 and 2021. We performed perioperative swallowing function tests, including the repetitive saliva swallowing test (RSST), maximum phonation time (MPT), and laryngeal elevation (LE). Patients with recurrent laryngeal nerve palsy (RLNP) and respiratory complications (RC) had significantly lower postoperative RSST scores than patients without them; the scores in patients with or without anastomotic leakage (AL) were similar. Postoperative MPT in patients with RLNP was shorter than that in patients without RLNP; however, it was similar to that in patients with or without AL and RC. LE was not associated with any complications. Patients with an RSST score ≤2 at 2 weeks post-esophagectomy had significant weight loss at 1, 6, and 12 months postoperatively compared with patients with an RSST score ≥3. The proportion of patients with severe weight loss (≥20% weight loss) within 1 year of esophagectomy was significantly greater in patients with RSST scores ≤2 than in those with RSST scores ≥3. Multivariate analysis showed that an RSST score ≤2 was the only predictor of severe post-esophagectomy weight loss. RSST scoring is a simple tool for evaluating post-esophagectomy swallowing function. A lower RSST score is associated with postoperative RLNP, RC, and poor nutritional status.

2.
In Vivo ; 36(5): 2314-2322, 2022.
Article in English | MEDLINE | ID: mdl-36099109

ABSTRACT

BACKGROUND/AIM: This study aimed to investigate the prognostic significance of preoperative anemia in gastric cancer patients. PATIENTS AND METHODS: The medical records of 801 patients with gastric cancer who underwent gastrectomy at the Nara Medical University hospital, were reviewed. Anemia was defined as a hemoglobin (Hb) level of <10 g/dl. Multivariate analysis was performed to identify prognostic factors. RESULTS: The mean Hb level was 13.1 (SD=2.0). Sixty-four (8.0%) patients were classified into the anemic group. Anemic patients were significantly older than nonanemic patients (p=0.007). Anemia was significantly associated with cardiovascular disease (p=0.041), chronic renal failure (p<0.001), tumor depth (p<0.001), and lymph node metastasis (p=0.001). The overall survival (OS) and cause-specific survival (CSS) rates of anemic patients were significantly lower in comparison to the nonanemic patients (p<0.001). In a subgroup analysis, the OS rate of anemic patients was significantly lower than that of nonanemic patients among patients with stage I and stage II disease. According to a multivariate analysis, preoperative anemia was an independent prognostic factor for OS (p<0.001), but not CSS (p=0.555). The rate of non-cancer deaths among anemic patients was significantly higher than that among nonanemic patients (p<0.001). CONCLUSION: Preoperative anemia is a simple and reliable predictor of poor prognosis, and it is associated with a higher risk of non-cancer death.


Subject(s)
Anemia , Stomach Neoplasms , Anemia/complications , Gastrectomy , Humans , Prognosis , Retrospective Studies , Stomach Neoplasms/complications , Stomach Neoplasms/surgery
3.
Nutr Cancer ; 74(8): 2838-2845, 2022.
Article in English | MEDLINE | ID: mdl-35129004

ABSTRACT

This study retrospectively investigated the prognostic impact of the geriatric nutritional risk index (GNRI) in colorectal cancer (CRC). This study reviewed the medical records of 329 CRC patients who underwent curative surgery. The GNRI was calculated from the serum albumin level and the body weight. The cutoff value for the GNRI was set at 98. One hundred ninety (57.8%) patients had a GNRI of ≥98, and 139 (42.9%) had a GNRI of <98. The patients with a lower GNRI had a significantly lower overall survival (OS) rate than those with a higher GNRI (p < 0.001). The multivariate analysis demonstrated that the GNRI was an independent predictor of the OS (p = 0.042). Non-cancer death was more frequent in the patients with a lower GNRI than in those with a higher GNRI (p = 0.003). The mean age was significantly higher in the patients with a lower GNRI (p < 0.001). The GNRI was significantly associated with tumor location (p = 0.048), tumor depth (p < 0.001) and carcinoembryonic antigen (CEA) level (p = 0.032). The GNRI is a simple and useful prognostic factor in CRC. The present study suggests that a low GNRI be associated with a higher risk of non-cancer death.


Subject(s)
Colorectal Neoplasms , Nutrition Assessment , Aged , Colorectal Neoplasms/surgery , Geriatric Assessment , Humans , Nutritional Status , Prognosis , Retrospective Studies , Risk Factors
4.
Gan To Kagaku Ryoho ; 47(13): 2113-2116, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33468878

ABSTRACT

BACKGROUND: The aim of this study was to investigate the prognostic impact of postoperative systemic inflammation in patients with colorectal cancer(CRC). METHODS: This study reviewed the medical records of 382 patients with CRC who underwent curative surgery. We evaluated the postoperative serum C-reactive protein(CRP)level on postoperative day 1 (CRP1)and its peak value(CRPmax)as prognostic factors. RESULTS: CRP1(p=0.001)and CRPmax(p=0.023)were significantly associated with the overall survival(OS)rate. In the multivariate analysis, a high-CRP1, age of≥75 years, and high serum carcinoembryonic antigen level were identified as independent predictors for the poor OS. Death from relapse of CRC was more frequent in the high-CRP1 group than in the low-CRP1 group(18.0% vs 5.6%, p=0.001). CONCLUSIONS: The serum CRP level during the early postoperative period predicts the long-term outcomes in CRC.


Subject(s)
C-Reactive Protein , Colorectal Neoplasms , Biomarkers, Tumor , C-Reactive Protein/analysis , Carcinoembryonic Antigen , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/surgery , Humans , Neoplasm Recurrence, Local , Postoperative Period , Prognosis , Retrospective Studies
5.
Surg Case Rep ; 5(1): 146, 2019 Oct 21.
Article in English | MEDLINE | ID: mdl-31637551

ABSTRACT

BACKGROUND: Although primary duodenal adenocarcinoma (DA) is a rare malignancy representing ~ 0.5% of all gastrointestinal cancers, the incidence of DA is more frequent in Lynch syndrome. Because of its rarity, treatment strategies or optimal chemotherapeutic regimens have not been clearly defined for advanced DA. CASE PRESENTATION: A 72-year-old woman with Lynch syndrome visited our hospital with a right upper abdominal pain. Computed tomography (CT) showed wall thickness with enhancement in the second portion of the duodenum and adjacent abdominal wall, which suggested direct tumor invasion to the abdominal wall. Upper gastrointestinal endoscopy (UGE) showed a large ulcerative tumor in the second portion of the duodenum, and histological analysis revealed a poorly differentiated adenocarcinoma. A cT4N0M0, cStage IIB (Union for International Control Cancer TNM staging) DA was diagnosed. After three courses of chemotherapy with S-1 and oxaliplatin (SOX), follow-up CT and UGE showed shrinkage of the duodenal tumor. Therefore, the patient underwent pancreaticoduodenectomy with lymph node dissection with curative intent. Histological examination showed a pathological complete response to SOX therapy. The postoperative course was uneventful, and the patient was discharged on postoperative day 29. The patient received no adjuvant chemotherapy, and there has been no evidence of recurrence 6 months after the operation. CONCLUSIONS: SOX therapy provided a remarkable response and can be an optimal chemotherapeutic regimen for advanced DA in Lynch syndrome.

6.
J Clin Pathol ; 71(5): 402-411, 2018 May.
Article in English | MEDLINE | ID: mdl-28924059

ABSTRACT

AIMS: Prostate cancer (PrCa) is the most frequently diagnosed non-cutaneous cancer in men. Without clear pathological indicators of disease trajectory at diagnosis, management of PrCa is challenging, given its wide-ranging manifestation from indolent to highly aggressive disease. This study examines the role in PrCa of the Pygopus (PYGO)2 chromatin effector protein as a risk stratification marker in PrCa. METHODS: RNA expression was performed in PrCa cell lines using Northern and RT-PCR analyses. Protein levels were assessed using immunoblot and immunofluorescence. Immunohistochemistry was performed on tissue microarrays constructed from radical prostatectomies with 5-year patient follow-up data including Gleason score tumour staging, margin and lymph node involvement and prostate serum antigen (PSA) levels. Biochemical recurrence (BR) was defined as a postoperative PSA level of >0.2 nL. Univariate and multivariate analyses were performed using SAS and Kaplan-Meier curves using graphPad (Prism). RESULTS: In vitro depletion of PYGO2 by RNAi in both androgen receptor positive and negative PrCa cell lines attenuated growth and reduced Ki67 and 47S rRNA expression, while PYGO2 protein was localised to the nuclei of tumours as determined by immunohistochemistry. High expression levels of PYGO2 in tumours (n=156) were correlated with BR identified as PSA progression, after 7-year follow-up independent of other traditional risk factors. Most importantly, high PYGO2 levels in intermediate grade tumours suggested increased risk of recurrence over those with negative or weak expression. CONCLUSION: Our data suggest that elevated PYGO2 expression in primary prostate adenocarcinoma is a potential risk factor for BR.


Subject(s)
Adenocarcinoma/metabolism , Adenocarcinoma/surgery , Biomarkers, Tumor/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Kallikreins/blood , Prostate-Specific Antigen/blood , Prostatectomy , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/surgery , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Biomarkers, Tumor/genetics , Cell Line, Tumor , Cell Proliferation , Disease Progression , Disease-Free Survival , Humans , Immunohistochemistry , Intracellular Signaling Peptides and Proteins/genetics , Kaplan-Meier Estimate , Male , Multivariate Analysis , Neoplasm Grading , Neoplasm Staging , Predictive Value of Tests , Proportional Hazards Models , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , RNA Interference , Risk Factors , Time Factors , Tissue Array Analysis , Transfection , Treatment Outcome , Up-Regulation
7.
Br J Nutr ; 114(5): 734-45, 2015 Sep 14.
Article in English | MEDLINE | ID: mdl-26234346

ABSTRACT

The aim of this study was to investigate the effects of the administration of oral arachidonic acid (AA) in rats with or without dextran sulphate sodium (DSS)-induced inflammatory bowel disease. Male Wistar rats were administered AA at 0, 5, 35 or 240 mg/kg daily by gavage for 8 weeks. Inflammatory bowel disease was induced by replacing drinking water with 3 % DSS solution during the last 7 d of the AA dosing period. These animals passed loose stools, diarrhoea and red-stained faeces. Cyclo-oxygenase-2 concentration and myeloperoxidase activity in the colonic tissue were significantly increased in the animals given AA at 240 mg/kg compared with the animals given AA at 0 mg/kg. Thromboxane B2 concentration in the medium of cultured colonic mucosae isolated from these groups was found to be dose-dependently increased by AA, and the increase was significant at 35 and 240 mg/kg. Leukotriene B4 concentration was also significantly increased and saturated at 5 mg/kg. In addition, AA at 240 mg/kg promoted DSS-induced colonic mucosal oedema with macrophage infiltration. In contrast, administration of AA for 8 weeks, even at 240 mg/kg, showed no effects on the normal rats. These results suggest that in rats with bowel disease AA metabolism is affected by oral AA, even at 5 mg/kg per d, and that excessive AA may aggravate inflammation, whereas AA shows no effects in rats without inflammatory bowel disease.


Subject(s)
Arachidonic Acid/adverse effects , Colitis/metabolism , Colon/drug effects , Cyclooxygenase 2/metabolism , Inflammation/metabolism , Inflammatory Bowel Diseases/pathology , Peroxidase/metabolism , Animals , Arachidonic Acid/metabolism , Colon/metabolism , Colon/pathology , Dextran Sulfate , Diet , Inflammatory Bowel Diseases/chemically induced , Inflammatory Bowel Diseases/metabolism , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Leukotriene B4/metabolism , Macrophages/metabolism , Male , Rats, Wistar , Thromboxane B2/metabolism
8.
Biochim Biophys Acta ; 1818(1): 12-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21958667

ABSTRACT

Caveolin-1 has a segment of hydrophobic amino acids comprising approximately residues 103-122 that are anchored to the membrane with cholesterol-rich domains. Previously, we reported that changing the Pro(110) residue to Ala (the P110A mutant) prevents not only the localization of the protein into lipid rafts but also the formation and functioning of caveolae. The conformational state of caveolin-1 can be shifted toward the transmembrane arrangement by this single amino acid mutation. To model the conformation, and extent of membrane insertion of this segment into membrane-mimetic environments, we have prepared a peptide corresponding to this hydrophobic segment of caveolin-1 having the sequence KKKKLSTIFGIPMALIWGIYFAILKKKKK-amide and the mutated version, KKKKLSTIFGIAMALIWGIYFAILKKKKK-amide. These peptides contain flanking Lys residues to facilitate purification and handling of the peptide. Circular dichroism measurements demonstrated that the mutated peptide has increased helical content compared with the wild type both in the presence and absence of lipid. The fluorescence emission from the Trp residues in the peptide showed significant blue shifts in the presence of liposomes, however the presence of cholesterol in hydrated vesicle bilayers decreases its helical content. Our overall findings support our studies with the intact protein in cells and suggest that the peptide of WT caveolin-1 hydrophobic segment has an intrinsic preference not to maintain its conformation as a rigid transmembrane helix. Substituting the Pro residue with an Ala allows the peptide to exist in a more hydrophobic environment likely as a consequence of a change in its conformation to a straight hydrophobic helix that traverses the membrane.


Subject(s)
Alanine/metabolism , Caveolin 1/metabolism , Lipid Bilayers/metabolism , Peptides/metabolism , Proline/metabolism , Alanine/chemistry , Amino Acid Sequence , Biomimetics , Caveolae/chemistry , Caveolae/metabolism , Caveolin 1/chemistry , Cholesterol/metabolism , Circular Dichroism , Hydrophobic and Hydrophilic Interactions , Lipid Bilayers/chemistry , Liposomes/chemistry , Liposomes/metabolism , Molecular Sequence Data , Peptides/chemical synthesis , Proline/chemistry , Protein Structure, Secondary , Protein Structure, Tertiary , Spectrometry, Fluorescence
9.
J Biol Chem ; 286(28): 25284-90, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21606504

ABSTRACT

Proteins interacting with membranes via a single hydrophobic segment can be classified as either monotopic or bitopic. Here, we probe the topology of a membrane-attached enzyme, the ε isoform of human diacylglycerol kinase (DGKε), when inserted into rough microsomes and compare it with the monotopic membrane protein mouse caveolin-1. In contrast to previous findings, the N-terminal hydrophobic stretch in DGKε attains a bitopic rather than a monotopic topology in our experimental system. In addition, we find that charged flanking residues as well as proline residues embedded in the hydrophobic segment are important determinants of monotopic versus bitopic topology.


Subject(s)
Caveolin 1/chemistry , Diacylglycerol Kinase/chemistry , Endoplasmic Reticulum/chemistry , Intracellular Membranes/chemistry , Animals , Caveolin 1/metabolism , Diacylglycerol Kinase/metabolism , Endoplasmic Reticulum/metabolism , Humans , Hydrophobic and Hydrophilic Interactions , Intracellular Membranes/metabolism , Mice , Microsomes/chemistry , Microsomes/metabolism , Protein Structure, Tertiary
10.
Molecules ; 16(5): 4278-94, 2011 May 24.
Article in English | MEDLINE | ID: mdl-21610657

ABSTRACT

Etoposide (VP-16) is an anti-tumor compound that targets topoisomerase II (top II). In this study, we have identified an alternative binding protein of etoposide by screening a library of T7 phage-displayed peptides. After four rounds of selection using a biotinylated etoposide derivative immobilized on a streptavidin-coated plate, T7 phage particles that display a 16-mer peptide NSSASSRGNSSSNSVY (ETBP16) or a 10-mer NSLRKYSKLK (ETBP10) were enriched with the ratio of 40 or 11 out of the 69 clones, respectively. Binding of etoposide to these peptides was confirmed by surface plasmon resonance (SPR) analysis, which showed ETBP16 and ETBP10 to have a kinetic constant of 4.85 × 10⁻5 M or 6.45 × 10⁻5 M, respectively. ETBP16 displays similarity with the ser-rich domain in E2F-4, a transcription factor in cell cycle-regulated genes, suggesting that etoposide might interact with E2F-4 via this domain. SPR analysis confirmed the specific binding of etoposide to recombinant E2F-4 is in the order of 10⁻5 M. Furthermore, etoposide was shown to inhibit luciferase reporter gene expression mediated by the heterodimeric E2F-4/DP complex. Taken together, our results suggest that etoposide directly binds to E2F-4 and inhibits subsequent gene transcription mediated by heterodimeric E2F-4/DP complexes in the nucleus.


Subject(s)
Carrier Proteins/metabolism , E2F Transcription Factors/metabolism , Etoposide/metabolism , Peptide Library , Amino Acid Sequence , Animals , Bacteriophage T7/metabolism , Biotinylation , CHO Cells , Cricetinae , Cricetulus , Drug Screening Assays, Antitumor , E2F Transcription Factors/genetics , Etoposide/analogs & derivatives , Etoposide/chemical synthesis , Etoposide/chemistry , Gene Expression Regulation , Genes, Reporter/genetics , Humans , Molecular Sequence Data , Peptides/chemistry , Peptides/metabolism , Protein Binding , Sequence Alignment , Structure-Activity Relationship
11.
J Biol Chem ; 285(43): 33371-33380, 2010 Oct 22.
Article in English | MEDLINE | ID: mdl-20729193

ABSTRACT

Caveolin-1 has a segment of hydrophobic amino acids comprising approximately residues 103-122. We have performed an in silico analysis of the conformational preference of this segment of caveolin-1 using PepLook. We find that there is one main group of stable conformations corresponding to a hydrophobic U bent model that would not traverse the membrane. Furthermore, the calculations predict that substituting the Pro(110) residue with an Ala will change the conformation to a straight hydrophobic helix that would traverse the membrane. We have expressed the P110A mutant of caveolin-1, with a FLAG tag at the N terminus, in HEK 293 cells. We evaluate the topology of the proteins with confocal immunofluorescence microscopy in these cells. We find that FLAG tag at the N terminus of the wild type caveolin-1 is not reactive with antibodies unless the cell membrane is permeabilized with detergent. This indicates that in these cells, the hydrophobic segment of this protein is not transmembrane but takes up a bent conformation, making the protein monotopic. In contrast, the FLAG tag at the N terminus of the P110A mutant is equally exposed to antibodies, before and after membrane permeabilization. We also find that the P110A mutation causes a large reduction of endocytosis of caveolae, cellular lipid accumulation, and lipid droplet formulation. In addition, we find that this mutation markedly reduces the ability of caveolin-1 to form structures with the characteristic morphology of caveolae or to partition into the detergent-resistant membranes of these cells. Thus, the single Pro residue in the membrane-inserting segment of caveolin-1 plays an important role in both the membrane topology and localization of the protein as well as its functions.


Subject(s)
Caveolae/metabolism , Caveolin 1/metabolism , Endocytosis/physiology , Proline/metabolism , Amino Acid Substitution , Animals , Caveolin 1/genetics , Cell Line , Humans , Mice , Mutation, Missense , Proline/genetics , Protein Structure, Secondary
12.
Int J Hematol ; 90(3): 397-401, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19705056

ABSTRACT

Only some carriers of human T cell lymphotropic virus type I (HTLV-1) develop adult T cell leukemia/lymphoma (ATLL) after a long latency period, and an association has been reported between chronic refractory eczema, known as infective dermatitis, and young-onset ATLL. A 25-year-old female developed ATLL and underwent allogeneic hematopoietic stem cell transplantation (HSCT) in non-remission. She had chronic refractory eczema and corneal injury at the onset of ATLL. Remission of ATLL was achieved, and the HTLV-1 proviral load decreased after HSCT. In addition, her pre-existing eczema and corneal injuries almost disappeared. More than a year has passed since the transplantation was performed, and she has had no recurrence of either ATLL or lesions in the skin and eye. Her clinical course suggests a possible association between skin and eye lesions and HTLV-1 infection. Changes in the immunological condition after HSCT might play a key role. Special attention is needed when HTLV-1 carriers develop eye or skin lesions.


Subject(s)
Corneal Diseases/therapy , Eczema/therapy , Hematopoietic Stem Cell Transplantation , Leukemia-Lymphoma, Adult T-Cell/therapy , Adult , Chronic Disease , Corneal Diseases/complications , Corneal Diseases/virology , Eczema/complications , Eczema/virology , Female , HTLV-I Infections/complications , Human T-lymphotropic virus 1 , Humans , Leukemia-Lymphoma, Adult T-Cell/complications , Leukemia-Lymphoma, Adult T-Cell/virology , Transplantation, Homologous , Treatment Outcome , Viral Load
13.
Cancer Sci ; 99(5): 1063-70, 2008 May.
Article in English | MEDLINE | ID: mdl-18380795

ABSTRACT

We previously reported that 3'-sulfoquinovosyl-1'-monoacylglycerol (SQMG) was effective in suppressing the growth of solid tumors due to hemorrhagic necrosis in vivo. In the present study, we investigated the antiangiogenic effect of SQMG. In vivo assessment of antitumor assays showed that some tumor cell lines, but not others, were sensitive to SQMG. Microscopic study suggested that in SQMG-sensitive tumors, but not SQMG-resistant tumors, angiogenesis was reduced. We next investigated gene expression relating to angiogenesis in tumor tissues by quantitative real-time polymerase chain reaction. Consequently, although vascular endothelial growth factor gene expression was not detected with significant differences among the cases, significant downregulation of Tie2 gene expression was observed in all SQMG-sensitive tumors as compared with controls, but not in SQMG-resistant tumors. These data suggested that the antitumor effects of SQMG could be attributed to antiangiogenic effects, possibly via the downregulation of Tie2 gene expression in SQMG-sensitive tumors.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Down-Regulation , Glycolipids/pharmacology , Neoplasms/blood supply , Neovascularization, Pathologic/enzymology , Protein Kinase Inhibitors/pharmacology , Receptor, TIE-2/genetics , Cell Line, Tumor , Dose-Response Relationship, Drug , Female , Humans , Male , Neovascularization, Pathologic/genetics , Receptor, TIE-2/metabolism
14.
J Antibiot (Tokyo) ; 59(10): 625-32, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17191677

ABSTRACT

Peptide libraries displayed by T7 phage, which contain random cDNA fragments insets, were screened for their ability to bind to a biotinylated derivative of clarithromycin. Phage particles bound to an immobilized derivative of the antibiotic were isolated and the inserted cDNA was amplified and sequenced. A common selected peptide sequence, composed of 19 amino acids, was obtained and a synthetic peptide with this sequence was produced. Surface plasmon resonance experiments showed that the synthetic peptide immobilized on a sensor chip bound to clarithromycin and the dissociation constant was determined to be 2.1 x 10(-3) M. The dissociation constants of other macrolide antibiotics, erythromycin, roxithromycin, azithromycin and josamycin were also determined to be 5.4 x 10(-3) M, 6.2 x 10(-5) M, 1.1 M and 3.4 x 10(-2) M, respectively. These results indicated that T7 phage display method might be useful to determine relatively weak interactions between small molecule drugs and the selected peptides which could represent a possible binding site conserved in binding proteins.


Subject(s)
Anti-Bacterial Agents/metabolism , Bacteriophage T7/genetics , Clarithromycin/metabolism , Peptide Library , Peptides/metabolism , Amino Acid Sequence , Biotinylation , Clarithromycin/analogs & derivatives , Gene Library , Ligands , Molecular Sequence Data , Molecular Structure , Peptides/chemistry , Peptides/genetics , Protein Binding , Surface Plasmon Resonance
15.
J Membr Biol ; 213(1): 11-8, 2006.
Article in English | MEDLINE | ID: mdl-17347779

ABSTRACT

The alpha-anomer form of sulfoquinovosyl-monoacylglycerol with a saturated C18 fatty acid (alpha-SQMG-C(18:0)) is a natural sulfolipid that is a clinically promising antitumor agent. It forms vesicles, micelles or an emulsion in water, depending on several physicochemical conditions. The type of aggregate formed appears to strongly influence the bioactivity level. Thus, we investigated the nature of the aggregates in relation to their bioactivities. The structure of the alpha-SQMG-C(18:0) assembly was greatly affected by the type of additive used in the preparation. Emulsification with ethanol and n-decane might be more effective at inhibiting tumor cell growth than the micelle or vesicle preparations. alpha-SQMG-C(18:0) formed an "emulsion-like-aggregate" in ethanol containing an n-decane concentration in the range of 1.03-103 mM: . These ethanol/n-alkane/alpha-SQMG-C(18:0) aggregates inhibited cell growth in a dose-dependent manner, under optimum conditions (i.e., ethanol containing 103 mM: of n-decane or n-dodecane dispersed in phosphate-buffered saline or culture medium). Based on these data, we discuss the relationship between the molecular action of and antitumor activity by alpha-SQMG-C(18:0).


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Glycolipids/administration & dosage , Glycolipids/pharmacokinetics , Alkanes/administration & dosage , Antineoplastic Agents/chemistry , Cell Division/drug effects , Cell Line, Tumor , Emulsions , Ethanol/administration & dosage , Glycolipids/chemistry , HeLa Cells , Humans , Micelles , Permeability , Solvents
16.
FEBS J ; 272(9): 2132-40, 2005 May.
Article in English | MEDLINE | ID: mdl-15853798

ABSTRACT

Sulfoquinovosylacylglycerols (SQAGs), in particular compounds with C18 fatty acid(s) on the glycerol moiety, may be clinically promising antitumor and/or immunosuppressive agents. They were found originally as inhibitors of mammalian DNA polymerases. However, SQAGs can arrest cultured mammalian cells not only at S phase but also at M phase, suggesting they have several molecular targets. A screen for candidate target molecules using a T7 phage display method identified an amino acid sequence. An homology search showed this to be a mammalian mitotic centromere-associated kinesin (MCAK), rather than a DNA polymerase. Analyses showed SQAGs bound to recombinant MCAK with a K(D)=3.1x10(-4) to 6.2x10-5 M. An in vivo microtubule depolymerization assay, using EGFP-full length MCAK fusion constructs, indicated inhibition of the microtubule depolymerization activity of MCAK. From these results, we conclude that clinically promising SQAGs have at least two different molecular targets, DNA polymerases and MCAK. It should be stressed that inhibitors of MCAK have never been reported previously so that there is a major potential for clinical utility.


Subject(s)
Antineoplastic Agents/metabolism , Glycolipids/metabolism , Immunosuppressive Agents/metabolism , Kinesins/metabolism , Amino Acid Sequence , Animals , Antineoplastic Agents/chemistry , CHO Cells , Cricetinae , DNA-Directed DNA Polymerase/metabolism , Drosophila melanogaster , Glycolipids/chemistry , Glycolipids/pharmacology , Humans , Immunosuppressive Agents/chemistry , Immunosuppressive Agents/pharmacology , Kinesins/genetics , Microtubules/metabolism , Molecular Sequence Data , Molecular Structure , Peptide Library , Protein Binding , Surface Plasmon Resonance
17.
Arch Phys Med Rehabil ; 86(3): 517-20, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15759238

ABSTRACT

OBJECTIVE: To investigate the common carotid blood flow volume and velocity in men with chronic low thoracic and lumbar spinal cord injury (SCI), using duplex sonography. DESIGN: Experimental control study. SETTING: University laboratory in a department of rehabilitation medicine. PARTICIPANTS: Twenty men with SCI between the T7 and L1 segments and 15 age- and sex-matched control subjects. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Common carotid artery flow volume and velocity. RESULTS: The mean carotid artery time-averaged flow velocity of subjects with SCI was significantly lower than that of control subjects. Moreover, the mean carotid flow volume of subjects with SCI was significantly lower than that of control subjects (right side: SCI, .52+/-.14 L/min; controls, .67+/-.10 L/min; P <.05; left side: SCI, .54+/-.15 L/min; controls, .72+/-.14 L/min; P <.05). CONCLUSIONS: There are reduced common carotid artery flow volumes and flow velocities in men with chronic SCI. The reduction may result from disturbances of blood distribution induced by reduced vasoconstriction tone below the level of SCI lesion.


Subject(s)
Carotid Arteries/diagnostic imaging , Lumbar Vertebrae , Spinal Cord Injuries/rehabilitation , Thoracic Vertebrae , Ultrasonography, Doppler, Duplex , Adult , Blood Flow Velocity , Blood Pressure , Heart Rate , Humans , Male , Middle Aged , Spinal Cord Injuries/diagnostic imaging
18.
Bioorg Med Chem Lett ; 14(16): 4343-6, 2004 Aug 16.
Article in English | MEDLINE | ID: mdl-15261299

ABSTRACT

SQAG9, a new class of immunosuppressive sulfoquinovosylacylglycerol, and its biotinylated derivatives have been synthesized. A T7 Phage library, composed of random cDNA fragments from Drosophila melanogaster, displayed a possible binding peptide of 14 amino acids. The immobilized synthetic peptide on a sensor chip showed a dissociation constant of K(D)=1.5 x 10(-6) against SQAG9 in a surface plasmon resonance experiment.


Subject(s)
Bacteriophage T7/genetics , Glycolipids/chemical synthesis , Immunosuppressive Agents/chemical synthesis , Peptides/metabolism , Animals , Drosophila melanogaster , Glycolipids/metabolism , Immunosuppressive Agents/metabolism , Magnetic Resonance Spectroscopy , Mass Spectrometry , Protein Binding , Surface Plasmon Resonance
SELECTION OF CITATIONS
SEARCH DETAIL
...